Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

83.01 -1.41 (-1.67%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,779,119
Open 84.42
Bid (Size) 83.00 (1)
Ask (Size) 83.09 (3)
Prev. Close 84.42
Today's Range 82.09 - 84.78
52wk Range 82.09 - 134.63
Shares Outstanding 2,531,374,696
Dividend Yield 3.71%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
MarketBeat Week in Review – 02/10 - 02/14
Despite many negative headlines, stocks are trading near all-time highs; next week will be a shortened trading week, with most of the monthly economic data in 
Via MarketBeat
Topics Credit Cards Economy Government
Exposures Interest Rates Political Tariff

Performance

YTD
-16.30%
-16.30%
1 Month
-17.57%
-17.57%
3 Month
-14.03%
-14.03%
6 Month
-27.45%
-27.45%
1 Year
-35.04%
-35.04%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Decoding Merck & Co's Options Activity: What's the Big Picture?
Via Benzinga
Recent Filing Shows That Rep. Josh Gottheimer Sold Over $54K Worth of Merck & Co Stock
Via Benzinga
Market Whales and Their Recent Bets on MRK Options
Via Benzinga
In a market where value is scarce, NYSE:MRK offers a refreshing opportunity with its solid fundamentals.
Via Chartmill
MRK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Rosen Law Firm Urges Merck & Co., Inc. (NYSE: MRK) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Top 3 Health Care Stocks You'll Regret Missing This Month
Via Benzinga
Why Merck Stock Is Plummeting Today
Via The Motley Fool
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
Via Benzinga
Topics Government
Exposures Political
3 Blue-Chip Dividend Stocks Trading at Multiyear Lows
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
Rosen Law Firm Encourages Merck & Co. Inc. Investors to Inquire About Securities Class Action Investigation – MRK
From The Rosen Law Firm, P.A.
Via Business Wire
Neuphoria Stock Jumps On Triggering $15M Milestone Payment From Merck For Alzheimer's Study: Retail Interest Explodes
Via Stocktwits
Gilead Sciences Beats Q4 EPS Forecast
Via The Motley Fool
Merck Stock Heads For 5th Day Of Losses As TD Cowen Downgrades On Gardasil Woes, But Retail Holds Strong
Via Stocktwits
Merck: 4 No-Brainer Reasons to Buy This Dip
Via MarketBeat
Better High-Yield Dividend Stock: Pfizer vs. Merck
Via The Motley Fool
Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
From Merck & Co., Inc.
Via Business Wire
Analysts Defend Merck Amid Investor Concerns Over Weak Guidance
Via Benzinga
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Merck (MRK) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Looking for the most active stocks in the S&P500 index on Tuesday?
Via Chartmill
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.